You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Trading
Institutions
Fees
Promotions
FAQ
Education
Download
About us
Hong Kong
uSMART
EN
Login/Register
Market News

Market News

HomeMarket NewsDetails

英國藥廠葛蘭素史克季績及全年業績預測均勝預期

阿思達克 01-31 15:47
英國藥廠葛蘭素史克(GSK)公布去年第四季業績。季度純利3.5億英鎊，每股季度純利8.6便士，經調整後為28.9便士，市場預期為28.63便士。季度收入80.52億英鎊，按年升9%，市場預期為72.9億英鎊。 公司預期現年度經調整每股盈利按年升6%至9%，即最少1.644英鎊；銷售按年升5%至7%，即最少318.4億英鎊。市場預期分別為每股1.545英鎊及310億英鎊。
葛蘭素史克(GSK.US)
20240616葛蘭素史克GSK
Relevant Stocks
葛蘭素史克(GSK.US)
Business Collaboration
Account Opening

Services

FeesFAQExclusive Trading Tools

About Us

OverviewContact UsMedia Center

Agreement Statement

DisclaimerPrivacy Statement
Contact Us
Customer Service Hotline︰+852 3018 4526
Email︰cs@usmarthk.com
Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong
WhatsApp︰+852 5989 2641
Join the Community：
uSMART-Facebook-Page
uSmart Securities Limited
is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Copyright © 2022 uSMART . All Rights Reserved.